metaMe Health partners with Indegene to launch Regulora®, an FDA-cleared Prescription Digital Therapeutic for adults with Irritable Bowel Syndrome

3 years ago

PRINCETON, N.J. and CHICAGO, March 22, 2022 (GLOBE NEWSWIRE) -- Indegene, a technology-led global healthcare solutions provider, and metaMe Health,…

Revelation Biosciences Inc. to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC

3 years ago

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life…

AGTC Announces Pricing of Public Offering of Common Stock

3 years ago

GAINESVILLE, Fla., and CAMBRIDGE, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical-stage biotechnology…

Yield10 Bioscience to Present at the Maxim Group 2022 Virtual Growth Conference and Participate in Fireside Chat

3 years ago

WOBURN, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,…

BioCorRx to Participate in Two Upcoming Conferences

3 years ago

ANAHEIM, CA, March 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of…

Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retirement of Harry Connick From His Director Role

3 years ago

ACTON, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs…

Integra LifeSciences Launches NeuraGen® 3D Nerve Guide Matrix

3 years ago

The Next Generation of Nerve Conduits NeuraGen 3D Nerve Guide Matrix NeuraGen 3D Guide Matrix, a resorbable implant for the…

Sharps Compliance Announces New $36.0 Million Credit Facility

3 years ago

HOUSTON, March 22, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national…

POINT Biopharma Confirms No Delays to SPLASH Trial Due to Recent Global Lutetium Supply Interruption

3 years ago

POINT’s industry-leading radioisotope supply chain enabled company to avoid delaysINDIANAPOLIS, March 22, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc.…